"What is the CONQUER Registry and what do patients need to know?"
Presented by Dr. Tracy Frech, of the University of Utah, and Dr. Shervin Assassi, of the University of Texas-Houston, on Tuesday, April 20th at 12:00PM CST/10:00AM PST
Scleroderma Research Foundation Research
Learn about our world-class research program
Landmark paper sheds new light on why immune responses of females and males differ
From SRF-funded researcher Dr. Howard Chang, Dr. Bingfei Yu, and Dr. Chang’s group at Stanford University
Learn about how the SRF was founded.
Participate in Research
Learn how you can be involved.
What SRF does…
Find a cure for Scleroderma
The SRF is the United States’ leading nonprofit investor in scleroderma research and is laser-focused on finding a cure for this rare and often deadly disease. Led by the most distinguished scientific minds, the SRF research program seeks to understand scleroderma by facilitating research and collaboration among the world’s top scientists and medical institutions.
The CONQUER Registry
The CONQUER Registry is the first nationwide longitudinal registry for scleroderma patients in the United States. Led by the SRF and a group of clinicians from twelve major academic centers, this potentially transformative endeavor was launched in 2018.
Cool Comedy • Hot Cuisine
Since 1987, SRF’s Cool Comedy • Hot Cuisine has been fortunate to have had some of the world’s finest performing artists generously donate their time and talents to help fundraise millions of dollars for scleroderma research and increase awareness about this chronic, debilitating and sometimes deadly autoimmune disease affecting thousands of people worldwide.
Advocate for the Patient Community
The SRF is dedicated to supporting patients and their caregivers as they learn about how to best manage the challenges of scleroderma. Through supporting Scleroderma Patient Days at a variety of Scleroderma Centers, the SRF webinar series featuring the field’s leading clinicians and researchers and its other publications, the SRF works to educate patients and others about the disease.